OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice

Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction

Debra E. Irwin, Zoë Kopp, Barnabie Agatep et al. · British Journal of Urology · 2011 · 987 citations

Anticholinergic Drug Exposure and the Risk of Dementia

Carol Coupland, Trevor Hill, Tom Dening et al. · JAMA Internal Medicine · 2019 · 560 citations · Full text

Overactive bladder significantly affects quality of life.

Paul Abrams, Con Kelleher, Lindsey A. Kerr et al. · PubMed · 2000 · 484 citations

Quality Of Life, Single Questionnaire, Urology +9

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Christopher R. Chapple, Karl‐Dietrich Sievert, Scott MacDiarmid et al. · European Urology · 2013 · 401 citations

Urological Research, Urology, Voiding Dysfunction +5

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

Victor W. Νitti, Roger R. Dmochowski, Sender Herschorn et al. · The Journal of Urology · 2012 · 399 citations